News for Novartis India Limited (NOVARTIND.BO)

Novartis India clarifies no involvement in Alkem Labs acquisition talks, stock price rises over 7 percent.

Stocks related to infrastructure, railways, defence, capital goods, power, real estate, financials, fertilizer, manufacturing, textiles, agrochemicals and more will be in focus ahead of the Union Budget 2024.

Buzzing Stocks Today, Stocks that will see action today: May 10, 2024 - Gold ETFs, LIC, Tata Steel, Adani Enterprises, Vodafone Idea, ICICI Lombard GIC, BLS International, Signature Global, Route Mobile, Solara Active, Brigade Enterprises

Nity on Tuesday ended 140 points lower to form a long negative candle pattern with a minor lower shadow on the daily chart and found support around the 50-day exponential moving average at 22,240 levels.

The quarterly earnings season commenced in the second week of April and remains ongoing, with more than 260 companies slated to announce their fourth-quarter earnings throughout this week.

In this week, BSE Sensex lost 1,475.96 or 0.99 percent to end at 72,643.43 and Nifty50 shed 470.25 points or 2.09 percent to finish at 22,023.30. The BSE Smallcap index posted its biggest weekly losses since December 2022 as it plunged 6 percent in the week

Foreign institutional investors (FIIs) curtained their selling during the week as they sold equities worth of Rs 816.91 crore, while Domestic institutional investors (DIIs) continued their support as they bought equities worth Rs 14,147.5 crore.

The drug is slated to be manufactured at Novartis' overseas manufacturing facilities and will be imported into India

Shahani, 74, was Novartis’ India chief when the Swiss drugmaker was involved in a brutal 7-year patent battle over its blood cancer drug Glivec.

Ranjit Shahani, was an influential figure in Indian pharma,and former President of OPPI. With a mechanical engineering degree from IIT Kanpur and an MBA from JBIMS Bombay, Shahani held notable positions at ICI and Roche Products before joining Novartis in 1997.

Ranjit Shahani, former Vice Chairman and Managing Director of Novartis India and Chairman of JB Pharmaceuticals, has passed away.

The management of Dr Reddy's has also repeatedly expressed their interest in acquiring a domestic-focused portfolio

Quess Corp demerges into three entities; LIC receives ₹25,464.46 crore refund; Novartis reviews Novartis India; Tiger Logistics splits shares.

Drug major Novartis AG has initiated a strategic review of Novartis India Ltd amid reports of putting the India listed business on the block.

Novartis AG conducts strategic review of Novartis India Limited, separate from Novartis Healthcare Private Limited in India.

India Business News: Pharma giant Novartis AG is conducting a strategic review of Novartis India, including its shareholding in the BSE listed company. The review's outcom

For the week, BSE Sensex and Nifty50 indices gained 1 percent each

Q3 results today: A total of 82 listed companies including Tata Technologies, Vedanta, Adani Power, SBI Life Insurance, and Punjab National Bank, are set to unveil their Q3FY24 results on January 25

Q2 results 2023 news: Apart from the Dussehra stock market holiday, widely tracked companies such as Reliance Industries and Maruti Suzuki will declare their earnings this week.